Chinook Therapeutics
Latest round
- Series A
Last raised
- Feb 2019
Total raised
- $65M
Investors
- 3
About Chinook Therapeutics
Founded in 2019 and based in Washington, US, Chinook Therapeutics Inc. is a biotechnology company that develops therapeutics based on single-cell RNA (ribonucleic acid) sequencing, human-derived organoids, and new translational models for the treatment of kidney diseases. In August 2020, Chinook Therapeutics Inc. In June 2020, Chinook and Aduro Biotech, Inc. announced a definitive merger agreement. After this transaction which was closed in the second half of 2020, Aduro was renamed Chinook Therapeutics, Inc. and trades on the Nasdaq under the ticker symbol KDNY. In November 2021, Chinook Therapeutics Inc.4 million shares at USD 14 per share on the Nasdaq. Among the products in Chinook’s pipeline are Atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a phase 1b trial for IgA nephropathy. In addition, Chinook is advancing CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria. Chinook Therapeutics Inc.
Who invested in Chinook Therapeutics
3 investors across 1 round
See all investors in Chinook Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 6, 2019
Amount
$65M
Investors
Questions about Chinook Therapeutics
Who invested in Chinook Therapeutics?
Chinook Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chinook Therapeutics raised?
Chinook Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Chinook Therapeutics last raise money?
Chinook Therapeutics's most recent round on record is a Series A, in Feb 2019.
What does Chinook Therapeutics do?
Founded in 2019 and based in Washington, US, Chinook Therapeutics Inc.
Where is Chinook Therapeutics headquartered?
Chinook Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Chinook Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Chinook Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Chinook Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.